HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Diagnosis, prevention and treatment of renal lesion in extracorporeal shock wave lithotripsy].

Abstract
The diagnosis and treatment of 120 patients with urolithiasis were made. The following examinations were made: the study of immune status and lipid peroxidation, detection of selective proteinuria, leukocyte migration inhibition reaction with autoantigens obtained from the tissues of the renopelvic segment providing additional information about renal parenchyma and immune system. The patients were divided into two groups: 70 patients of the study group received pre-, intra- and postoperative preventive pharmacotherapy, while 50 patients of the control group received standard therapy. It is shown that preventive measures in the patients of the study group aimed at raising resistance of the kidney to the shock wave and prevention of infectious-inflammatory process evidence for necessity of the above measures not only before extracorporeal shock wave lithotripsy, but also in intra- and postoperative periods.
AuthorsT N Nazarov, V P Aleksandrov, V V Mikhaĭlichenko, D G Koren'kov, S N Kalinina, V A Semenov, A E Krivenko, S A Guliamov
JournalUrologiia (Moscow, Russia : 1999) (Urologiia) 2007 Jul-Aug Issue 4 Pg. 6-10 ISSN: 1728-2985 [Print] Russia (Federation)
PMID17918318 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Autoantigens
Topics
  • Adult
  • Autoantigens (immunology, metabolism)
  • Female
  • Humans
  • Infection Control
  • Infections (immunology, pathology, therapy)
  • Inflammation (diagnosis, genetics, immunology, pathology, prevention & control, therapy, urine)
  • Kidney Pelvis (immunology, metabolism, pathology)
  • Lithotripsy
  • Male
  • Middle Aged
  • Proteinuria (diagnosis, immunology, pathology, prevention & control, therapy, urine)
  • Urolithiasis (diagnosis, immunology, pathology, prevention & control, therapy, urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: